Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Assets Average (2023 - 2025)

Historic Assets Average for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $18.7 million.

  • Mangoceuticals' Assets Average rose 2445.82% to $18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7 million, marking a year-over-year increase of 2445.82%. This contributed to the annual value of $8.2 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Mangoceuticals' Assets Average stood at $18.7 million, which was up 2445.82% from $21.3 million recorded in Q2 2025.
  • Mangoceuticals' 5-year Assets Average high stood at $21.3 million for Q2 2025, and its period low was $676120.0 during Q1 2024.
  • Moreover, its 3-year median value for Assets Average was $15.0 million (2024), whereas its average is $11.2 million.
  • The largest annual percentage gain for Mangoceuticals' Assets Average in the last 5 years was 264539.79% (2025), contrasted with its biggest fall of 2445.82% (2025).
  • Quarter analysis of 3 years shows Mangoceuticals' Assets Average stood at $1.3 million in 2023, then soared by 1039.8% to $15.1 million in 2024, then rose by 23.91% to $18.7 million in 2025.
  • Its Assets Average stands at $18.7 million for Q3 2025, versus $21.3 million for Q2 2025 and $18.6 million for Q1 2025.